Company intelligence / Profile preview

BioPhotas

Tustin, California, United Statescelluma.com ↗

Ownership: Private
Employees: ~30
Development stage: Commercial

Overview

BioPhotas' Celluma devices are FDA-cleared for multiple indications including acne, wrinkles/aging skin, pain relief, body contouring, and hair restoration. The company has won numerous industry awards for innovation and efficacy. Clinical studies support the safety and effectiveness of their biophotonics-based technology for both professional and consumer use in over 85 countries worldwide.

Therapeutic areas: OtherDermatologyRheumatology
Modalities: Device (LED light therapy device)Non-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

None specifically disclosed in public sources as of June 2025. Company distributes globally through a network of partners.

Beyond the preview

Go deeper on BioPhotas.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioPhotas.

Explore the full profile